Investors

Copyright West LLC. Minimum 15 minutes delayed.

SEC Filings

Filing date Description Form Filing Group Issuer View

Registration of a class of securities of certain Canadian issuers pursuant to Section 12(b) of the 1934 Act

40-F
Annual Filings
Immunovaccine Inc. EX-101.INS - XBRL INSTANCE FILE View HTML

40FR12B

40FR12B
Other
Immunovaccine Inc. View HTML

40FR12B/A

40FR12B/A
Other
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML